About Catalyst OrthoScience
Catalyst OrthoScience is a private company based in Naples, Florida. It has reported $24,605,369 raised in four offerings on Form D since November 2017. Its chief executive is Carl O'Connell.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 29, 2025 | Jul 31, 2025 | $4,135,604of $6.0M target | 3 | $1.3M | EquityRule 506(b) | Form D ↗ |
| Apr 5, 2024 | Apr 18, 2024 | $1,499,999of $5.0M target | 2 | $749K | EquityRule 506(b) | Form D ↗ |
| May 17, 2023 | Sep 7, 2023 | $15,369,766fully sold | 81 | $189K | EquityRule 506(b) | Form D ↗ |
| Nov 15, 2017 | Nov 29, 2017 | $3,600,000of $4.0M target | 26 | $138K | EquityRule 506(c) | Form D ↗ |
| Total, four offerings | $24,605,369 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Catalyst OrthoScience's Form D filed Jul 31, 2025.
WW
Wayne Wallace
Director
DS
Derace Schaffer
Director
DF
Dan Fleming
Director
CC
Carl O'Connell
CEO and director
CM
Carter McNabb
Director
Earlier filings also listed Steven Goldberg (director, last listed Apr 2024), Cameron Rubino (director, last listed Apr 2024), Robert Kaufman (ceo and chairman, last listed Nov 2017) and David Wood (director, last listed Nov 2017).